Original Source(s)
Related Content
ECP 2026: Combined Approach Predicts Metastasis in Prostate Cancer
Integrating spatial transcriptomics and machine learning may predict lymph node metastasis in treatment-naive prostate cancer
September 17, 2026
-
3 min
FDA clears targeted cholangiocarcinoma therapy
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
-
2 min